Inventor · disambiguated record
G. Leslie Burnett
Also filed as: BURNETT G LESLIE
11 granted patents·17 pending applications·56 citations·filing 2019–2025
89Inventor score
Files withREVOLUTION MEDICINES INC28
Top patents by PatentIndex Score
28 records- 0196US11739074B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Aug 29, 2023·9 cites·2 claims
- 0295US12202845B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Granted Jan 21, 2025·3 cites·6 claims
- 0395US11685749B2C26-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jun 27, 2023·5 cites·8 claims
- 0495US11364300B2C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jun 21, 2022·6 cites·11 claims
- 0595US10980889B1C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Apr 20, 2021·8 cites·6 claims
- 0694US12252497B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Granted Mar 18, 2025·3 cites·10 claims
- 0794US12187746B2C26-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Jan 7, 2025·5 cites·9 claims
- 0894US11690915B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2021·Granted Jul 4, 2023·9 cites·2 claims
- 0994US11168102B1Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2020·Granted Nov 9, 2021·5 cites·18 claims
- 1093US12048749B2C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Granted Jul 30, 2024·3 cites·10 claims
- 1188US2025145643A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 1279US2023106174A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Application pending·0 cites
- 1376US2025074923A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 1476US2025361245A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 1575US2025051306A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 1675US2023374035A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 1773US12258366B2Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2022·Granted Mar 25, 2025·0 cites·14 claims
- 1869US2025368661A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
- 1968US2019336609A1C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR InhibitorsREVOLUTION MEDICINES INC·Filed 2019·Application pending·0 cites
- 2067US2025197423A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 2167US2025154171A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 2265US2024262847A1Covalent ras inhibitors and uses thereofREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 2364US2023093861A1Rapamycin analogs as mtor inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Application pending·0 cites
- 2464US2021139517A1Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2020·Application pending·0 cites
- 2561US2025388598A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
- 2660US2021094975A1Rapamycin analogs as mtor inhibitorsREVOLUTION MEDICINES INC·Filed 2019·Application pending·0 cites
- 2758US2023100838A1Covalent ras inhibitors and uses thereofREVOLUTION MEDICINES INC·Filed 2022·Application pending·0 cites
- 2854US2025269037A1Compounds, complexes, and methods for their preparation and of their useREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when G. Leslie Burnett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →